Typhoid Vi polysaccharide vaccine

伤寒Vi多糖疫苗（沃森生物）

Report date: 2025/03/26 20:01:25

Base Information

Drug NameTyphoid Vi polysaccharide vaccine
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid FeverSalmonella Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYuxi Walvax Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co LtdYuxi Walvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSalmonella Infections
Inactive IndicationsTyphoid Fever

Other Information

ATC CodeN/A
Related LinksN/A